BWPO Quality Incentive Program: Quantification of Cross-Contamination of Pathology Samples
NOTE: THERE IS NO ACTION NECESSARY IN ETHOS TO COMPLETE THIS TRAINING. THE DEPARTMENT WILL TRACK COMPLETION AND SUBMIT COMPLETION REPORTS TO THE QIP TEAM. PLEASE SEE BELOW FOR THE MEASURE DETAILS AND THE QIP'S LAST DATA REFRESH.
Genetic identity testing using unique short tandem repeats is known as DNA fingerprinting. The applicability of this type of testing in quality control and quality assurance space is relatively new; the methodology provides a highly sensitive tool to address specimen misidentification and/or tissue contamination (referred to as floaters or contaminate tissue fragments). The department will establish a baseline (index) of expected vs. unexpected results. After the routine workup, each case will be assigned the attribute expected vs. unexpected result and a team discussion (Huddle) will be performed to assign Positive vs. Negative to calculate the final index.
COMPLETION DATA REFRESHED AS OF (N/A AT THIS TIME)